The Multi Disciplinary Committee (MDC) of Experts, which advices the National Pharmaceutical Pricing Authority (NPPA) on pricing related matters, has decided to call Sanofi India in its next meeting to present the company’s case with regard to its application for higher price for certain combinations of its diabetes drug Soliqua. The company applied for retail […]